Therapeutic Drug Monitoring Study of Reduced-Dose Efavirenz (400 mg) in Combo Tablet for Patients Receiving Atripla With Viral Suppression in Taiwan
NCT03595709
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
3-in-1 tablet (EFV 400mg, TDF 300mg, 3TC 300mg)
Sponsor
Yu-Jay Corp.